Characteristic morphological signs of the brain damage during chronic hepatitis C virus infection identified in autopsy samples

Cover Page


Cite item

Full Text

Abstract

Background: The central nervous system damage is one of the most common extra hepatic manifestations of chronic hepatitis C viral (HCV) infection, with the prevalence of up to 50% of the infected cases. Previous studies have identified the main clinical, pathogenetic and neurometabolic features of this pathology, which make it possible to suggest its definite nosological independence. However, the morphological pattern of brain lesions in chronic HCV infection remains virtually unexplored, significantly limiting the possibility of comprehensive pathological diagnosis of the disease. Aim: To study morphological patterns and to identify typical and diagnostically significant pathological signs of brain involvement in chronic HCV infection. Materials and methods: This was a retrospective descriptive cross-sectional study performed with a range of immunohistochemical (IHC) and pathomorphological techniques in the autopsy brain samples from patients who died of chronic HCV infection (40 cases) and those who died without any signs of past mental and infectious disorders (the control group, 15 cases). Results: The сharacteristic morphological signs of HCV-associated brain injury are IHC expression of the NS3 viral marker, an increase in CD68-positive microglial cell count, white brain matter microgliosis, perivascular and diffuse round cell inflammatory infiltration, degeneration and loss of neurons, neurophagy, demyelination, axonal degeneration, perivascular sclerosis, fibrous cell gliosis, small perivascular hemorrhages, focal hemosiderosis and calcification. The parameters of the identified abnormalities differ significantly depending on the brain region (p < 0.001). The identification of the HCV NS3 marker in the nervous tissue has the definitive diagnostic value. Conclusion: The body of histopathological abnormalities found in various parts of the brain from the infected patients represents the morphological equivalent of the clinical and functional manifestations of HCV-associated cerebral dysfunction. The results obtained can be used to improve the pathological diagnostics of brain lesions in chronic HCV infection; their implementation is feasible in routine pathological practice.

About the authors

A. M. Maybogin

Moscow Helmholtz Research Institute of Eye Diseases

Author for correspondence.
Email: uvb777@rambler.ru
ORCID iD: 0000-0003-1582-2106

Artemij M. Maybogin – Medical Researcher, Pathologist, Department of Eye Pathology and Histology.

14/19 Sadovaya-Chernogryazskaya ul., Moscow, 105062
Tel.: +7 (965) 107 24 75 

Россия

References

  1. Kuna L, Jakab J, Smolic R, Wu GY, Smolic M. HCV extrahepatic manifestations. J Clin Transl Hepatol. 2019;7(2):172–82. doi: 10.14218/JCTH.2018.00049.
  2. Lingala S, Ghany MG. Natural history of hepatitis C. Gastroenterol Clin North Am. 2015;44(4): 717–34. doi: 10.1016/j.gtc.2015.07.003.
  3. Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut. 2006;55(11):1624–30. doi: 10.1136/gut.2005.080267.
  4. Yarlott L, Heald E, Forton D. Hepatitis C virus infection, and neurological and psychiatric disorders – A review. J Adv Res. 2017;8(2):139–48. doi: 10.1016/j.jare.2016.09.005.
  5. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35(2):433–9. doi: 10.1053/jhep.2002.30688.
  6. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2003;9(6):847–54. doi: 10.1017/S1355617703960048.
  7. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 2004;78(10): 5170–83. doi: 10.1128/jvi.78.10.51705183.2004.
  8. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002;76(2):600–8. doi: 10.1128/jvi.76.2.600-608.2002.
  9. Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009;83(3):1312–9. doi: 10.1128/JVI.01890-08.
  10. Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology. 2012;142(3):634–43.e6. doi: 10.1053/j.gastro.2011.11.028.
  11. Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut. 2011;60(3):370–7. doi: 10.1136/gut.2010.217976.
  12. Pawlowski T, Radkowski M, Małyszczak K, Inglot M, Zalewska M, Jablonska J, Laskus T. Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation. J Clin Virol. 2014;60(2):105–11. doi: 10.1016/j.jcv.2014.03.004.
  13. Bolay H, Söylemezoğlu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg. 1996;98(4):305–8. doi: 10.1016/03038467(96)00040-6.
  14. Seifert F, Struffert T, Hildebrandt M, Blümcke I, Brück W, Staykov D, Huttner HB, Hilz MJ, Schwab S, Bardutzky J. In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion. Eur J Neurol. 2008;15(3):214–8. doi: 10.1111/j.1468-1331.2007.02044.x.
  15. Grover VP, Pavese N, Koh SB, Wylezinska M, Saxby BK, Gerhard A, Forton DM, Brooks DJ, Thomas HC, Taylor-Robinson SD. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 2012;19(2):e89–96. doi: 10.1111/j.13652893.2011.01510.x.
  16. Forton DM, Hamilton G, Allsop JM, Grover VP, Wesnes K, O'Sullivan C, Thomas HC, Taylor-Robinson SD. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol. 2008;49(3):316–22. doi: 10.1016/j.jhep.2008.03.022.
  17. Чубинидзе АИ. К методике гистологического (морфологического) определения степени поражения центральной нервной системы. Архив патологии. 1972;34(11):77–8.
  18. Herder V, Hansmann F, Wohlsein P, Peters M, Varela M, Palmarini M, Baumgärtner W. Immunophenotyping of inflammatory cells associated with Schmallenberg virus infection of the central nervous system of ruminants. PLoS One. 2013;8(5):e62939. doi: 10.1371/journal.pone.0062939.
  19. Майбогин АМ, Недзьведь МК, Карапетян ГМ. Метод морфологической диагностики микроглиоза в белом веществе головного мозга: инструкция по применению. Утверждено Министерством здравоохранения Республики Беларусь 11.11.2014. Гомель: Гомельский государственный медицинский университет; 2014. 18 с.
  20. Майбогин АМ, Недзьведь МК. Микроглиоз в белом веществе головного мозга при хронической HCV-инфекции: морфологическое исследование. ВИЧ-инфекция и иммуносупрессии. 2019;11(3):49–56. doi: 10.22328/2077-9828-2019-11-3-49-56.
  21. Younis LK, Talaat FM, Deif AH, Borei MF, Reheim SM, El Salmawy DH. Immunohistochemical detection of HCV in nerves and muscles of patients with HCV associated peripheral neuropathy and myositis. Int J Health Sci (Qassim). 2007;1(2):195–202.
  22. Hjerrild S, Renvillard SG, Leutscher P, Sørensen LH, Østergaard L, Eskildsen SF, Videbech P. Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C. Metab Brain Dis. 2016;31(2):311–9. doi: 10.1007/s11011-015-9752-3.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Maybogin A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies